Does delayed urticaria induced by drug allergy exist?
Main Article Content
Keywords
Drug allergy, Delayed urticaria, Drug reactions
Abstract
With the help of a routine clinical case about delayed urticaria induced by drug, we have analyzed the scientific societies reports published during the last 5 years on this topic.
We highlighted the differences between the EAACI consensus and documents on drug allergy, commenting their positions and some of their definitions on delayed urticaria.
However, the question of disagreement between definitions of delayed urticaria can generate confusion. It would be beneficial to have more and ‘‘official’’ clearness about this topic because of its important clinical application to our patients.
References
[2]. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues Cernadas J, et al. In vitro tests for drug hypersensitivity reactions. An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy. 2016;71:1103-34.
[3]. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139:683-93.
[4]. Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet JC, et al. EAACI position paper on how to classify cutaneous manifestation of drug hypersensitivity. Allergy. 2018;74:14-27.
[5]. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel T, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int. 2015;24:94-105.
[6]. Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, et al. Towards a more precise diagnosis of hypersensitivity to beta-lactams -an EAACI position paper. Allergy. 2019.
[7]. Blumenthal KG, Peter JG, Trubiano JS, Phillips EJ. Antibiotic allergy. Lancet. 2019;393:183-98.
[8]. Romano A, Valluzzi RL, Caruco C, Maggioletti M, Gaeta F. Nonimmediate cutaneous reactions to beta-lactams: approach to diagnosis. Curr Allergy Asthma Rep. 2017;17:23.
[9]. Atanaskovic-Markovic M, Gaeta F, Medjo B, Gavrovic-Jankulovic M, Velickovic CT, Tmusic V, et al. Non-immediate hypersensitivity reactions to beta lactam antibiotics in children our 10-year experience in allergy work-up. Pediatr Allergy Immunol. 2016;27:533-8.
[10]. Alaaddin Y, Akın F, Sert A, Ag˘ır MA, Yılmaz R, Arslan S. Demographic and clinical characteristics of patients with serum sickness-like reaction. Clin Rheumatol. 2017;37:1389-94.
[11]. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393-414.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.